4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-069142
Director sold 500,000 shares at $9.33 ($4,666,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Noble James Director | 2020-05-29 | Sale | −500,000 | $9.33 | $4,666,000 | 0 | D |
| Open-market sales · 500,000 sh · avg $9.33 · $4,666,000 | |||||||
Loading xslF345X03/a4.xml…